Your Complete 16-Week Wegovy Dose Chart Cost Breakdown
Complete Wegovy Dose Chart Monthly Cost Analysis
Our detailed Wegovy dose chart reveals the true monthly investment required for successful weight management treatment in the UK. The mandatory 16-week escalation schedule means predictable monthly costs: £79.99 for weeks 1-4 (0.25mg), £94.99 for weeks 5-8 (0.5mg), £99.99 for weeks 9-12 (1mg), and £139.99 for weeks 13-16 (1.7mg). Understanding this Wegovy dose chart progression helps patients budget effectively for their transformation journey.
The maintenance phase beginning at week 17 represents the most significant monthly investment at £209.99 for the 2.4mg dose, but also delivers the full therapeutic benefit seen in clinical trials. Our Wegovy dose chart calculator shows an annual maintenance cost of £2,519.88 (12 months × £209.99), making this prescription-only medicine a substantial but worthwhile investment in your long-term health. Planning ahead with our transparent Wegovy dose chart ensures no surprises in your weight management budget.
Wegovy Dose Chart Pricing with UK Bundle Advantages
Beyond individual pen pricing, our Wegovy dose chart includes strategic bundle options designed for treatment continuity. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks, while the Progress Trio (0.5mg, 1mg & 1.7mg) provides 12 weeks of escalation for £369.99. These bundles complement our Wegovy dose chart by reducing ordering frequency and ensuring uninterrupted supply during critical escalation phases.
For maintenance treatment, the Ultimate Stability Trio delivers three months of 2.4mg pens for £649.99, representing excellent value in our Wegovy dose chart structure. New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to maintain competitive pricing throughout their journey. Our GPhC-registered pharmacy (#9012878) ensures every Wegovy dose chart calculation reflects legitimate, regulated pricing for this prescription-only medicine.
Clinical Evidence Supporting Wegovy Dose Chart Escalation
The carefully structured Wegovy dose chart escalation protocol is based on robust clinical evidence from the STEP trial programme. In clinical trials, patients following this exact Wegovy dose chart progression achieved an average clinically studied weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The graduated dosing schedule in our Wegovy dose chart minimises gastrointestinal side effects while optimising therapeutic outcomes.
STEP 1 trial data demonstrates why the Wegovy dose chart cannot be accelerated or modified - the 16-week escalation ensures optimal tolerability and efficacy. Patients in STEP trials following this precise Wegovy dose chart protocol showed sustained weight management success, with the maintenance 2.4mg dose providing continued appetite regulation and metabolic benefits throughout the treatment period.
How Wegovy Works Throughout the Dose Chart Progression
Wegovy (semaglutide) functions as a GLP-1 receptor agonist, mimicking natural hormones that regulate appetite and food intake at every stage of our dose chart progression. As doses escalate according to the Wegovy dose chart schedule, patients experience enhanced satiety signalling to the brain, reducing hunger between meals and promoting feeling full with smaller portions. The graduated increase shown in our Wegovy dose chart allows your body to adapt to semaglutide's appetite-suppressing effects while building therapeutic levels. Each dose escalation in the Wegovy dose chart strengthens the medication's ability to reduce food cravings and support portion control. By the maintenance 2.4mg dose, patients typically experience optimal appetite regulation supporting their reduced-calorie diet and increased physical activity programme.
Wegovy Dose Chart Ordering Process at EverydayMeds
Accessing treatment following our Wegovy dose chart begins with a straightforward 3-minute online clinical assessment covering your weight management goals and medical history. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring the Wegovy dose chart protocol suits your individual circumstances as a prescription-only medicine. Once approved, your first Wegovy dose chart pen ships via next-day cold-chain delivery, maintaining the 2-8°C temperature requirements for optimal medication integrity. Subsequent orders follow your personal Wegovy dose chart schedule, with automatic reminders ensuring seamless progression through each escalation phase. Our GPhC-registered pharmacy (#9012878) ensures authentic Novo Nordisk Wegovy pens supporting your complete dose chart journey from first injection to maintenance treatment.
Wegovy Dose Chart Storage and Practical Administration
Proper storage following your Wegovy dose chart schedule requires refrigeration at 2-8°C before first use, though pens can remain at room temperature below 30°C for up to 6 weeks once removed from the fridge. Each Wegovy dose chart injection uses Novo Nordisk's intuitive FlexTouch pen, delivering precise doses with minimal discomfort when administered weekly on the same day. The escalation timeline in our Wegovy dose chart cannot be modified - skipping doses or accelerating progression may compromise treatment effectiveness and increase side effect risk. Rotating injection sites between thigh, abdomen, and upper arm as detailed in our Wegovy dose chart guidance prevents tissue irritation and ensures consistent absorption. Following the complete Wegovy dose chart protocol maximises your investment in this prescription-only medicine while supporting sustainable weight management outcomes.
Long-term Financial Planning with Wegovy Dose Chart Costs
Unlike one-time treatments, our Wegovy dose chart represents an ongoing investment in weight management, requiring careful financial planning for sustained success. The initial 16-week escalation totals £514.96, but the real consideration involves annual maintenance costs of £2,519.88 for continued 2.4mg treatment. Many patients find the monthly £209.99 maintenance cost more manageable than the cumulative annual figure, spreading this investment across 12 smaller payments rather than viewing it as a £2,500 annual commitment.
Strategic use of our bundle pricing within the Wegovy dose chart framework helps manage cash flow while ensuring treatment continuity. The Ultimate Stability Trio provides quarterly maintenance supply for £649.99, reducing ordering frequency to four times yearly while securing three months of uninterrupted treatment. DOSE25 discount code for returning customers helps maintain competitive pricing throughout your long-term Wegovy dose chart journey, ensuring cost predictability as you progress from escalation through maintenance phases.
Start Your Wegovy Dose Chart Journey Today
Beginning your weight management transformation with our comprehensive Wegovy dose chart starts at just £79.99 for new customers using code FIRST40 at checkout. Returning patients continue their progression with DOSE25, maintaining competitive pricing throughout every phase of the escalation schedule. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and begin following our structured dose chart protocol under qualified medical supervision. Our transparent pricing across the complete Wegovy dose chart removes uncertainty from your weight management investment, while cold-chain delivery ensures medication integrity from our GPhC-registered pharmacy. Transform your relationship with food and achieve sustainable weight management by following our evidence-based Wegovy dose chart progression alongside your reduced-calorie diet and increased physical activity programme.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
